The Office of Research and Sponsored Programs (ORSP) has received an award notice from the REDIzone for a new award with funding in the amount of $10,000 to support the project titled “Serum levels of glycated ApoAI, a novel biomarker to screen for pre-diabetes and diabetes and their cardiovascular complications” for the period of May 8, 2020 to November 7, 2020.